These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19244663)

  • 1. Some side effects of breast cancer treatment may be a good sign.
    Harv Womens Health Watch; 2009 Jan; 16(5):6. PubMed ID: 19244663
    [No Abstract]   [Full Text] [Related]  

  • 2. Aromatase inhibitors and arthralgias: a new frontier in symptom management for breast cancer survivors.
    Burstein HJ; Winer EP
    J Clin Oncol; 2007 Sep; 25(25):3797-9. PubMed ID: 17761968
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant therapy of breast cancer - bisphosphonates.
    Saarto T
    Cancer Treat Res; 2009; 151():163-77. PubMed ID: 19593512
    [No Abstract]   [Full Text] [Related]  

  • 4. The significance of distant metastases in breast cancer.
    Blackwell KL
    Breast; 2008 Jan; 17 Suppl 1():S1-2. PubMed ID: 18279762
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimising care of elderly breast cancer patients: a challenging priority.
    Tipples K; Robinson A
    Clin Oncol (R Coll Radiol); 2009 Mar; 21(2):118-30. PubMed ID: 19111450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatment.
    Shoda H; Inokuma S; Yajima N; Tanaka Y; Setoguchi K
    Ann Rheum Dis; 2005 Apr; 64(4):651-2. PubMed ID: 15769928
    [No Abstract]   [Full Text] [Related]  

  • 7. Aromatase inhibitors as adjuvant therapy for breast cancer.
    Montemurro F; Aglietta M; Del Mastro L
    J Clin Oncol; 2009 May; 27(15):2566-7. PubMed ID: 19332706
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary: anthracyclines in early-stage breast cancer: is it the end of an era?
    Pritchard KI
    Oncologist; 2009 Oct; 14(10):959-62. PubMed ID: 19819915
    [No Abstract]   [Full Text] [Related]  

  • 9. New pharmacogenomic paradigm in breast cancer treatment.
    Offit K; Robson ME
    J Clin Oncol; 2010 Nov; 28(31):4665-6. PubMed ID: 20876427
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant chemotherapy and cognitive dysfunction in breast cancer patients.
    J Support Oncol; 2006 Feb; 4(2):66-7. PubMed ID: 16499119
    [No Abstract]   [Full Text] [Related]  

  • 11. The fog hasn't lifted on "chemobrain" yet: ongoing uncertainty regarding the effects of chemotherapy and breast cancer on cognition.
    Vardy J; Dhillon H
    Breast Cancer Res Treat; 2010 Aug; 123(1):35-7. PubMed ID: 20052534
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictors of toxicity and toxicity profile of adjuvant chemotherapy in elderly breast cancer patients.
    Garg P; Rana F; Gupta R; Buzaianu EM; Guthrie TH
    Breast J; 2009; 15(4):404-8. PubMed ID: 19508671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer.
    Schwartzberg LS; Cobb P; Senecal F; Henry D; Kulig K; Walker MS; Houts AC; Stepanski EJ
    Breast; 2009 Apr; 18(2):78-83. PubMed ID: 19342237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice.
    Sánchez-Muñoz A; Ribelles N; Márquez A; Pérez-Ruiz E; Alba E
    J Clin Oncol; 2009 Dec; 27(35):e255-6; author reply e257-8. PubMed ID: 19884520
    [No Abstract]   [Full Text] [Related]  

  • 15. Cognitive side-effects of adjuvant treatments.
    Burstein HJ
    Breast; 2007 Dec; 16 Suppl 2():S166-8. PubMed ID: 17719225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated cutaneous nodulosis associated with aromatase inhibitor therapy in a patient with rheumatoid arthritis.
    Chao J; Parker BA; Zvaifler NJ
    J Rheumatol; 2009 May; 36(5):1087-8. PubMed ID: 19435976
    [No Abstract]   [Full Text] [Related]  

  • 17. Fresh weapons for an old battle.
    Underwood A
    Newsweek; 2004 May; 143(19):64, 66, 69. PubMed ID: 15164552
    [No Abstract]   [Full Text] [Related]  

  • 18. Myelotoxicity in cancer patients treated with chemotherapy: negative or positive prognostic factor?
    Koutras AK; Kalofonos HP
    Clin Cancer Res; 2008 Nov; 14(22):7579. PubMed ID: 19010877
    [No Abstract]   [Full Text] [Related]  

  • 19. Understanding ductal carcinoma in situ. Most women diagnosed with this noninvasive breast cancer are alive 10 years later, and better treatments are emerging.
    Harv Womens Health Watch; 2008 Oct; 16(2):1-3. PubMed ID: 19051424
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of aromatase inhibitors' side effects in clinical and experimental studies].
    Kubatka P; Péc M
    Klin Onkol; 2009; 22(3):89-93. PubMed ID: 19708541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.